Unexplained recurrent miscarriage: how can we explain it?
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Unexplained recurrent miscarriage (RM) can be a challenging and frustrating condition for both patients and clinicians. For the former, there is no diagnosis available for consolation, while for the latter there is little evidence-based treatment to offer. However, the majority of these patients have an excellent prognosis without the need for any treatment. Epidemiological associations suggest that the reason for this is that the majority of women with unexplained RM are in fact healthy individuals, with no underlying pathology, who have suffered three miscarriages purely by chance. Nevertheless, a certain proportion of women with unexplained RM will continue to miscarry, and preliminary studies suggest the presence of pathology in some women of this group. As a result, two types of unexplained RM can be described: Type I unexplained RM, which occurs by chance in women who have no underlying pathology and has a good prognosis; and Type II unexplained RM, which occurs due to an underlying pathology that is currently not yet identified by routine clinical investigations and has a poorer prognosis. Distinguishing between Types I and II unexplained RM can be achieved by considering several factors: the age of the woman, the definition used for RM (i.e. whether biochemical pregnancy losses are considered as miscarriages), the number of previous miscarriages suffered and the karyotype of the products of conception, where available. A better understanding of the two types of unexplained RM could lead to more targeted referrals, investigations and treatments, which would improve cost-effectiveness and overall clinical care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sporadic miscarriage (occurring most commonly in the first trimester) is often the result of random fetal chromosomal anomalies.1,2”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [2]
In the citing paper
“although it has been recognised that a significant proportion of women with unexplained recurrent miscarriage may be healthy women with repeated sporadic miscarriages and no persisting pathology.2,7”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [2]
Citations
Cites
Maternal age and fetal loss: population based register linkage study
Andersen, A.-M. N. (2000) · BMJ · doi:10.1136/bmj.320.7251.1708 · Cited by 1,690 · cited 9×
“For women of the general population aged 30–34, the SM rate is estimated to be 15% (Nybo Andersen et al., 2000).”
BackgroundInfluentialRai, R., & Regan, L. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69204-0 · Cited by 1,227
Rai, R., Cohen, H., Dave, M., & Regan, L. (1997) · BMJ · doi:10.1136/bmj.314.7076.253 · Cited by 1,113 · cited 1×
“Finally, there is strong evidence linking various pathological factors to RM, most notably antiphospholipid syndrome, which if treated have been shown to significantly improve pregnancy outcomes in women who would otherwise have a poor prognosis (Rai et al., 1997).”
BackgroundEmbryonic karyotype of abortuses in relation to the number of previous miscarriages
Ogasawara, M., Aoki, K., Okada, S., & Suzumori, K. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00495-1 · Cited by 604 · cited 2×
“, 2001) and a higher number of miscarriages (Ogasawara et al., 2000).”
BackgroundRecurrent miscarriage I: definition and epidemiology
Stirrat, G. M. (1990) · The Lancet · doi:10.1016/0140-6736(90)92159-f · Cited by 600 · cited 2×
“Consequently, the current knowledge stems from widely accepted estimates, which indicate that RM affects 1% of the general population (Stirrat, 1990; Jauniaux et al., 2006; Rai and Regan, 2006).”
BackgroundResultCytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study
Stephenson, M. D. (2002) · Human Reproduction · doi:10.1093/humrep/17.2.446 · Cited by 522
Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage
Jauniaux, E. (2006) · Human Reproduction · doi:10.1093/humrep/del150 · Cited by 520 · cited 1×
“Consequently, the current knowledge stems from widely accepted estimates, which indicate that RM affects 1% of the general population (Stirrat, 1990; Jauniaux et al., 2006; Rai and Regan, 2006).”
ResultEpidemiology and the medical causes of miscarriage
Regan, L., & Rai, R. (2000) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1053/beog.2000.0123 · Cited by 512 · cited 2×
“before the fetus has reached a viable gestational age (Regan and Rai, 2000).”
BackgroundStray-Pedersen, B., & Stray-Pedersen, S. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(84)80164-7 · Cited by 483 · cited 3×
“These studies have compared groups of women with and without exposure to supportive care, reporting increases in live birth rates of up to 50% (Stray-Pedersen and Stray-Pedersen, 1984; Liddell et al., 1991; Clifford et al., 1997).”
BackgroundAspirin plus Heparin or Aspirin Alone in Women with Recurrent Miscarriage
Kaandorp, S. P., Goddijn, M., van der Post, J. A. M., Hutten, B. A., Verhoeve, H. R., Hamulyák, K., Mol, B. W., Folkeringa, N., Nahuis, M., Papatsonis, D. N. M., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000641 · Cited by 450 · cited 1×
“Although no differences were shown for live birth rates, the women in the treatment group reported significant bruising, swelling and itching at their injection sites (Kaandorp et al., 2010).”
Background
Research works printed but not linked: 1
- 2008, Fertility and sterility, 90, S60
Cited by
Dimitriadis, E., Menkhorst, E., Saito, S., Kutteh, W. H., & Brosens, J. J. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00228-z · Cited by 702
Qiao, J., Wang, Y., Li, X., Jiang, F., Zhang, Y., Ma, J., Song, Y., Ma, J., Fu, W., Pang, R., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32708-2 · Cited by 569
The T helper type 17/regulatory T cell paradigm in pregnancy
Figueiredo, A. S., & Schumacher, A. (2016) · Immunology · doi:10.1111/imm.12595 · Cited by 283
Von Woon, E., Greer, O., Shah, N., Nikolaou, D., Johnson, M., & Male, V. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmac006 · Cited by 185
“…women with RM and normal foetal karyotype had worse prognoses for future pregnancies compared with sporadic foetal aneuploidy (Carp et al., 2001; Saravelos and Li, 2012), a systematic review found that incidence of chromosomal abnormalities, which accounted for 46% of RM, was not different from…”
Recurrent MiscarriageGreen‐top Guideline No. 17
Regan, L., Rai, R., Saravelos, S., Li, T., & the Royal College of Obstetricians and Gynaecologists (2023) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17515 · Cited by 158
Self-citation
Metadata
- Authors
- Saravelos, S. H., & Li, T.-C.
- Affiliations
- University of Sheffield (GB)
- Corresponding author
- Saravelos, S. H.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-05-02
- Volume
- 27
- Issue
- 7
- Pages
- 1882-1886
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2151658409
- Cited by
- 86
- References
- 35
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 8 · 2020: 12 · 2019: 5 · 2018: 5 · 2017: 8 · 2016: 6 · 2015: 4 · 2014: 12 · 2013: 4 · 2012: 1
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- unexplained recurrent spontaneous abortion, prognosis, biochemical pregnancy loss, maternal age, underlying disease
- MeSH terms
- Abortion, Spontaneous, Abortion, Habitual, Adult, Age Factors, Clinical Trials as Topic, Female, Humans, Karyotyping, Pregnancy, Pregnancy Complications, Prognosis, Karyotype
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.